Kim M Hirshfield

3PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 04, 2025
Factors influencing Patient Preferences for BRCA Testing and Adjuvant Therapy in HER2-Negative Early Breast Cancer in the United States: Best-Worst Scaling and Discrete Choice Experiment.

Kathryn Mishkin, Qixin Li, Jagadeswara Rao Earla

|Dec 09, 2024
Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study.

Jagadeswara Rao Earla, Kalé Kponee-Shovein, Allison W Kurian

|Mar 25, 2021
Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years.

Jan Sieluk, Lingfeng Yang, Amin Haiderali

Pageof 1

Frequent Collaborators

2 joint publications

Jagadeswara Rao Earla

1 joint publications

Kalé Kponee-Shovein

1 joint publications

Allison W Kurian

1 joint publications

Jaime A Mejia